Sort Results:
List of Materials
 |
Academic Drug Discovery in the Center for Integrative Chemical Biology and Drug DiscoveryLearn more about the Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina Chapel Hill . This presentation discusses the Center's vision, mission, capabilities, process and portfolio and highlights. ' |
Center for Integrative Chemical Biology and Drug Discovery University of North Carolina Chapel Hill Presenter: Stephen V. Frye, Ph.D. |
|
Academics in CNS Therapy DiscoveryThe business of drug discovery is changing. Pharma has historically played the principal role in small molecule drug development, and academia has traditionally conducted the basic research studies, providing pharma with the molecular targets to... |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Barbara Slusher, Ph.D., M.A.S. |
|
Alternative Approaches To Lead GenerationHistorically, drug discovery was chiefly an empirical enterprise, with the shift to a more hypothesis-driven approach occurring in the 20th century. Whereas originally drug discovery was focused primarily on identifying therapeutically useful agents... |
University of Kansas Medical Center Presenter: S.J. Enna, Ph.D. |
|
Changing Landscape of Drug Discovery in Industry SettingsThis lecture entitled “Changing Landscape of Drug Discovery in Industry Settings†introduces the drug discovery and development process to a class focused on a range of topics related to discovery and development of new therapeutic agents... |
Vanderbilt Center for Neuroscience Drug Discovery Vanderbilt University Presenter: P. Jeffrey Conn |
|
Drug Discovery and the Biopharmaceutical Ecosystem: The Imperative for New R&D Models “The Evolving Role of Academic Drug Discovery”This presentation by Dr. Steven Paul was the keynote address for the "Johns Hopkins Brain Science Institute's Drug Discovery in Academia: The new paradigm in drug discovery" conference.' |
Weill Cornell Medical College of Cornell University Presenter: Steven M. Paul, M.D. |
|
First-In-Man - risk assessmentThe example of TeGenero first-in-man case study was used to explore the usability of systems theoretic accident modeling and processes (STAMP) to create control structure of selected critical points in drug development, approval and... |
ARETE-ZOE, LLC Presenter: Veronika Valdova |
|
Funding Academic Drug DiscoveryThe NIH supports drug discovery and development for nervous system disorders through a variety of programs. Some provide funding through grants or cooperative agreements to support specific stages of research and development, for particular disease... |
NINDS Office of Translational Research Presenter: Rebecca Farkas, Ph.D. |
|
Introduction to Drug Discovery ResearchA lecture discussing the current status, historical perspective and the future challenges of Drug Discovery and Development. |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Takashi Tsukamoto, Ph.D. |
|
NeuroTranslational Drug Discovery ProgramLearn more about the Brain Science Institute NeuroTranslational Drug Discovery Program at Johns Hopkins. This presentation explains how the program got its start, the mission, the staff, the capabilities and future plans. |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Barbara Slusher, Ph.D. |
|
Risk, Issue and Opportunity in Drug DeveopmentHolistic risk, issue and opportunity management in drug development requires close coordination and alignment of approaches, strategies and tools across the whole program among all participating stakeholders to account for technical, business and... |
ARETE-ZOE, LLC Presenter: Veronika Valdova |